ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Bristol Myers Squibb Receives Positive CHMP Opinion for Onureg® for Adults with Acute Myeloid Leukemia in First Remission
April 26, 2021Bristol Myers Squibb has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended approval of Onureg® (azacitidine tablets; CC-486) as a maintenance therapy in adult patients with ... -
FDA approves first ever therapy for ultra rare primary haemophagocytic lymphohistiocytosis
November 22, 2018The partnership of Sobi and Novimmune has revealed that their interferon gamma (IFNγ) blocking antibody Gamifant (emapalumab-lzsg) has received approval from
Pharma Sources Insight January 2025
